[Serum Level of Programmed Cell Death 5 Protein Levels in Patients with Sepsis].

Hui-lin Liu,Qing Tian,Tian-pei Hong,Gui-hua Liu,Huan Pan,Hai-ning Wang,Hong-wei Gao
DOI: https://doi.org/10.3969/j.issn.1671-167x.2013.02.015
2013-01-01
Abstract:OBJECTIVE:To investigate the changes of serum programmed cell death 5 (PDCD5) levels in patients with critical illnesses including systemic inflammatory response syndrome (SIRS, except sepsis), sepsis (except severe sepsis) and severe sepsis.METHODS:A total of 78 patients were enrolled in this study, of whom, 28 were with SIRS, 23 with sepsis and 27 with severe sepsis. Twenty-two healthy individuals were included as controls. The levels of serum PDCD5 were evaluated by enzyme-linked immune sorbent assay. And the correlation analyses were made in the levels of sreum PDCD5 and acute physiology and chronic health evaluation II(APACHE II), high-sensitivity C-reactive protein(hs-CRP), white blood cell count, neutrophil count and age factors.RESULTS:Serum PDCD5 levels in the SIRS, sepsis and severe sepsis groups were (19.07 ± 8.91), (29.03 ± 13.27) and (42.83 ± 17.32) μg/L respectively, which were significantly higher than that in the healthy control group (0.32 ± 0.02) μg/L. Serum PDCD5 levels in SIRS, sepsis and severe sepsis groups were gradually increased with significant difference at any in-between comparison (P<0.05). Moreover, serum PDCD5 levels were positively correlated with the acute physiology and chronic health evaluation II (APACHE II) score (r=0.572, P<0.05).CONCLUSION:The serum PDCD5 levels in the critically ill patients with sepsis were progressively increased with the worsened condition. The up-regulated expression of PDCD5 may play an important role in the development and progression of sepsis.
What problem does this paper attempt to address?